Measurement of glucose-6-phosphate dehydrogenase and glutathione reductase activity in patients with paracoccidioidomycosis treated with ketoconazole
✍ Scribed by Benedito Barraviera; Rinaldo Poncio Mendes; Paulo Câmara Marques Pereira; Jussara Marcondes Machado; Paulo Roberto Curi; Domingos Alves Meira
- Publisher
- Springer Netherlands
- Year
- 1988
- Tongue
- English
- Weight
- 364 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0301-486X
No coin nor oath required. For personal study only.
✦ Synopsis
Hemoglobin rates, hematocrit and glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase activities were measured in 38 patients with paracoccidioidomycosis treated with ketoconazole or sulfadoxin, and in 13 normal individuals. Ketoconazole-treated patients showed reduced G6PD and glutathione reductase activities. One of these patients was found to be G6PD-deficient and suffered a hemolytic episode during treatment, which, however, did not require interruption of therapy. The authors suggest that patients showing an erythrocyte enzyme defect should be monitored hematologically during treatment with ketoconazole. They also suggest that ketoconazole is an oxidant drug in addition to being a possible inhibitor of antioxidant erythrocyte enzymes.
📜 SIMILAR VOLUMES
## ERUM LACTIC DEHYDROGENASE ACTIVITY (SLD) S has been studied in some hematological diseases and was found to be elevated in the sera of patients with acute stem cell leukemia, chronic myelogenous leukemia,2.5 megaloblastic anemia, sickle cell anemia,', 8 and in acute hemolytic episodes.4 Four s
There are two structural forms of glucose 6-phosphate dehydrogenase activity in Drosophila melanogaster. Whether one or the other or both show in vitro (and probably in vivo) activity depends on the genotype of a sex-linked locus (Zw). In this article, the relative fittnesses of heterozygotes (with